Amgen's FY2024 revenues of USD 33.4 billion grew 19% year-on-year, supported by the Horizon Therapeutics acquisition (bringing Tepezza for thyroid eye disease and other rare disease assets)
Despite these results, the development of AOD-9604 stopped in 2007
The fact that many peptide users are taking them for physical performance and healing reasons makes establishing those sorts of metrics harder, Spittler says
"People who really believe that that's the power of placebo." B12 has me like —@katyperry As a geriatrician at Mount Sinai Hospital in Toronto, Sinha said he commonly tests for B12 levels in patients "when we're assessing a person for dementia or a person with balance issues." Otherwise he said it's ineffective to take B12 supplements to prevent deficiency and there are even potential risks of over-doing it
Easy drive from La Grange Park, Western Springs, Hinsdale, Brookfield, Countryside, and Burr Ridge